Predictable Fast CD4+ Reconstitution and Prevention of Graft Failure in High-Risk Patients following Cord Blood Transplantation by Individualized Dosing and Therapeutic Drug Monitoring of Anti-Thymocyte Globulin
Rick Admiraal(NHS Blood and Transplant), Jaap Jan Boelens(Wilhelmina Children's Hospital), Caroline A. Lindemans(University Medical Center Utrecht), Birgitta Versluys(University Medical Center Utrecht), Lysette Ebskamp-van Raaij(University Medical Center Utrecht), Charlotte van Kesteren(NHS Blood and Transplant), Marc Bierings(University Medical Center Utrecht), Amelia M. Lacna(University Medical Center Utrecht), Stefan Nierkens(Utrecht University)
Cited by 1
Related Papers
Gut microbiome–derived metabolites modulate intestinal epithelial cell damage and mitigate graft-versus-host disease
|Nature Immunology|2016|727
Early cytomegalovirus reactivation remains associated with increased transplant-related mortality in the current era: a CIBMTR analysis
|Blood|2016|554
Defibrotide for prophylaxis of hepatic veno-occlusive disease in paediatric haemopoietic stem-cell transplantation: an open-label, phase 3, randomised controlled trial
|The Lancet|2012|376
Total Body Irradiation or Chemotherapy Conditioning in Childhood ALL: A Multinational, Randomized, Noninferiority Phase III Study
|Journal of Clinical Oncology|2020|333